Home › Funds › EVENTIDE ASSET MANAGEMENT, LLC › COLL

EVENTIDE ASSET MANAGEMENT, LLC position in COLL

COLLEGIUM PHARMACEUTICAL INC · Health Care

EVENTIDE ASSET MANAGEMENT, LLC reported holding 1,361,228 shares of COLL (COLLEGIUM PHARMACEUTICAL INC) in its Q2 2026 13F filing — a position valued at US$49.3M, representing 0.66% of its reported portfolio and ranking #49 among its reported holdings. EVENTIDE ASSET MANAGEMENT, LLC has disclosed COLL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.36M sh
Reported value held$49.27M
Portfolio Weight0.66%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How EVENTIDE ASSET MANAGEMENT, LLC's COLL position evolved

EVENTIDE ASSET MANAGEMENT, LLC first disclosed a stake in COLL in Q3 2023 at 2,631,334 shares (US$58.8M). The position peaked in Q1 2024 at 2,634,041 shares, worth US$102.3M. Across 12 filings, EVENTIDE ASSET MANAGEMENT, LLC increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 1,361,228 shares valued at US$49.3M — a reduction of -63,054 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.63M $58.81M New
Q4 2023 2.63M $80.97M Hold
Q1 2024 2.63M $102.25M Hold
Q2 2024 2.63M $84.84M Hold
Q3 2024 2.64M $101.83M Hold
Q4 2024 2.64M $75.60M Hold
Q1 2025 2.64M $78.79M Hold
Q2 2025 2.64M $78.11M Hold
Q3 2025 2.39M $83.65M Reduce
Q4 2025 1.88M $86.88M Reduce
Q1 2026 1.42M $47.08M Reduce
Q2 2026 1.36M $49.27M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COLL and 13F data

COLL (COLLEGIUM PHARMACEUTICAL INC) is a Health Care company. 32 other funds we track also report a position in COLL — the largest reported positions include TENOR CAPITAL MANAGEMENT Co., L.P. (US$85.8M), GOLDENTREE ASSET MANAGEMENT LP (US$26.9M), SILVERBACK ASSET MANAGEMENT LLC (US$18.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COLL

All COLL fund holders →

FAQ

How long has EVENTIDE ASSET MANAGEMENT, LLC held COLL?

EVENTIDE ASSET MANAGEMENT, LLC has disclosed COLL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is EVENTIDE ASSET MANAGEMENT, LLC's current position in COLL?

As of Q2 2026, EVENTIDE ASSET MANAGEMENT, LLC holds 1.36M shares of COLL (COLLEGIUM PHARMACEUTICAL INC), valued at $49.27M, representing 0.66% of its reported portfolio and ranking #49.

Has EVENTIDE ASSET MANAGEMENT, LLC been buying or selling COLL?

In the latest 13F filing (Q2 2026), EVENTIDE ASSET MANAGEMENT, LLC reduced its position in COLL. The position peaked in Q1 2024 at 2.63M shares.

Which other funds hold COLL?

Other major institutional holders of COLL include TENOR CAPITAL MANAGEMENT Co., L.P., GOLDENTREE ASSET MANAGEMENT LP, SILVERBACK ASSET MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.